About i Research www . marfan . fondation  ~~~~~~~~~~ Marfan Vision Foundation Inc.

Contributions to a 501(c)(3) Organizations            General Fund
The Foundation's operating and clerical expenses are paid from general contributions. All information provided by the Foundation is free. No salaries are paid to its  advisors. Operating expenses include the facility, computer hardware, software, phone services, internet access, website maintenance, printing, office supplies, data base maintenance, information gathering trips to eye institutes and research centers, production of educational materials about Marfan Vision Foundation, and much more.




 The www.Marfan.Foundation,  is a tax-exempt, non-profit organization. 
All donations are tax deductible.   Not for Profit  # N16000002319  (active status)
Marfan Vision Foundation Inc.



 Fed Tax ID: 
81-1473402
 
 
 President: Richard Gobout
  Vice president : Maria Gonzales
    Treasurer: Andre Lafasanela

 General Mail Address:  P.O.Box 290494
                                           Fort-Lauderdale, Florida 33329
                                           954-295-8999
                                                             CHARITY@MARFAN.FOUNDATION



+++++++++++++++++++++++++++++++++++++++++++++++++

See Conditions by First Letter

• Astigmatism study
• Cataract study
• Conjunctival Diseases study
• Conjunctivis study
• Corneal Diseases study
• Corneal Dystrophies Hereditary study
• Dilation Pathologic study
• Disease Attributes study
• Disease Susceptibility study
• Dry Eye Syndromes study
• Eye Diseases study
• Eye Diseases Hereditary study
• Eye Infections study
• Fuchs' Endothelial Dystrophy study
• Genetic Diseases Inborn study
• Hyperopia study
• Inflammation study
• Keratitis study
• Keratoconjunctivitis study
• Keratoconjunctivitis Sicca study
• Keratoconus study
• Lacerations study
• Lacrimal Apparatus Diseases study
• Myopia study
• Pathological Conditions Anatomical study
• Pellucid Marginal Degeneration study
• Presbyopia study
• Quality of Life study
• Refractive Errors study
• Rupture study
• Syndrome study

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
See Dietary Supplements by First Letter

• Folate study
• Folic Acid study
• Riboflavin study
• Vitamin B2 study
• Vitamin B9 study

                                                 SAMPLE list of possible Vision RESEARCH & EDUCATION

Early Changes Among FLEx, LASIK and FS-LASIK
Conditions:Myopia;   Astigmatism
Interventions:Procedure: lenticule extraction;   Procedure: laser in situ keratomileusis;   Procedure: FS assisted laser in situ keratomileusis.

High Resolution Wavefront-guided vs. Wavefront LASIK
Conditions:Nearsightedness;   Astigmatism
Intervention:Procedure: LASIK.  

 Safety nd Effectiveness of Wavefront-guided LASIK for the Correction of Mixed Astigmatism
Condition:Astigmatism
Intervention:Device: LASIK.  

Quality of Vision and Quality of Life with LASIK
Conditions:Myopia;   Astigmatism;   Quality of Lifte
Intervention:Other: Patient Quality of Life andVision after LASIK Surgery.

 Changes Between Lenticule Extraction and Femtosecond Laser_assisted Laser in Situ Keratomileusis
Conditions:Myopia;   Astigmatism
Interventions:Procedure: lenticule extraction;   Procedure: femtosecond laser-assisted laser in situ keratomileusis.

Corneal Power, Astigmation and Aberration Changes after LASIK
Condition:Measurements of Patients Using OCT Before and After LASIK
Intervention.  

A Prospective Safety and Effectiveness Study of the 500 Hz Technolas Perfect Vision Excimer Laser using LASIK.
Conditions:Myopia;   Hyperopia
Intervention:Device: Proscan.    

Can Pregabalin Reduce the Frequency and Severity of Dry Eye Symptoms after Laser assisted in Stu Keratomileusis
Condition:Dry Eye
Interventions:Drug: Pregabalin;   Drug: Placebo

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
   Publicly and privately supported research studies conducted in the United States and around the world. Sponsors or investigators of research and other international policies also require trials.
Each study record includes a summary of the study protocol, including the purpose, recruitment status, and eligibility criteria.    Study research locations and specific contact information  
Some study records include summary study results in a tabular format. The results information submitted  include the number of participants starting and completing the study, baseline characteristics, outcome measures, and adverse events. 

 Recruitment Status information.

SPONSOR      The sponsor is the organization or persons  Sponsor-Investigator who oversees the  study and is responsible for analyzing the study data.

COLLABORATORS     A collaborator is an organization other than the Sponsor that provides support for a  study. This support may include funding, design, implementation, data analysis, or reporting.

​INFORMATION PROVIDED BY (RESPONSIBLE PARTY) The contents of the study record are provided by this organization or person. This sponsor, sponsor-investigator, or sponsor-designated principal investigator is responsible for submitting information about a study and updating that information.

PURPOSE     This section explains what the researchers will do during the study and why they are conducting the study, including what condition is being studied and the questions that the researchers want to answer. General information, such as estimated enrollment and study start and completion dates, is also provided. You can find out what type of intervention participants receive, how long the participants receive the intervention. Details such as phase, study type, study design and official study title are also provided.
ELIGIBILITY    This section explains who is allowed to participate in the study. The most common criteria are listed first: ages eligible for study, genders eligible for study and whether the study accepts healthy volunteers. A list of additional inclusion and exclusion criteria is also provided in this section.

• Participant Flow. A tabular summary of the progress of participants through each stage of a study, by study arm or comparison group. It includes the numbers of participants who started, completed, and dropped out of each period of the study based on the sequence in which interventions were assigned.
• Baseline Characteristics. A tabular summary of the data collected at the beginning of a study for all participants, by study arm or comparison group. These data include demographics, such as age and gender, and study-specific measures (for example, systolic blood pressure, prior treatment).
• Outcome Measures and Statistical Analyses. A tabular summary of outcome measure values, by study arm or comparison group. It includes tables for each prespecified Primary Outcome and Secondary Outcome and may also include other prespecified outcomes, post hoc outcomes, and any appropriate statistical analyses.
• Adverse Events. A tabular summary of all anticipated and unanticipated serious adverse events and a tabular summary of anticipated and unanticipated other adverse events exceeding a specific frequency threshold. For each serious or other adverse event, the summary includes the adverse event term, affected organ system, number of participants at risk, and number of participants affected, by study arm or comparison group.

M. Vision Research Inc.  staff review results submissions to ensure that they are clear and informative before posting them to the Web site. However, M. Vision Foundation Inc.  cannot ensure scientific accuracy. Data providers are responsible for ensuring that their submitted information is accurate and complete.

---

---

Donors

• Joseph G.
• Andre Lafasanella
• .
•  .

Awards

• Angelica of Lids Inc.
• .Marjolaine Bourque (Translation)
• .
• .

Where to send Donations

Marfan Vision Foundation Inc.
P.O. Box 290494
Fort-Lauderdale,Florida 33329
​U.S.A.

Call: 954-295-8999
Email: CHARITY@MARFAN.FOUNDATION

Return Policy

    The Marfan  Foundation accepts voluntary donations from supporters in the form of Credit Cards, Stocks, Real Estate, Bequests in Wills, and Corporate Sponsorships. We accept these donations with the understanding the donation is a gift and not returnable.
 
 
 If you have any questions, please contact us at:

www . Marfan . Foundation

CHARITY@MARFAN.FOUNDATION
954-295-8999